PatentsGlobal
EU Pharma Package Expands Bolar Exemption: Insights from Türkiye and TRIPS Compliance Challenges
Originally designed to allow generic manufacturers to prepare regulatory submissions before patent expiry, the Bolar exemption is set for significant expansion under the EU Pharma Package. This includes coverage of activities like health technology assessments, pricing, reimbursement, and public procurement participat…
Tuesday, August 4, 2026